(Q38178783)

30 August 2017

title

Obstructive sleep apnoea and type 2 diabetes mellitus: a bidirectional association (English)

1 reference

30 August 2017

0 references

R Nisha Aurora

1

1 reference

30 August 2017

Naresh M Punjabi

series ordinal

2

1 reference

30 August 2017

publication date

1 May 2013

1 reference

The Lancet. Respiratory medicine

30 August 2017

published in

1 reference

30 August 2017

volume

1

1 reference

30 August 2017

issue

4

1 reference

30 August 2017

page(s)

329-338

1 reference

Economic impact of childhood obesity on health systems: a systematic review.

30 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970039-0

7 January 2021

Long-term impact of overweight and obesity in childhood and adolescence on morbidity and premature mortality in adulthood: systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970039-0

7 January 2021

Sleep loss: a novel risk factor for insulin resistance and Type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970039-0

7 January 2021

Effects of poor and short sleep on glucose metabolism and obesity risk

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970039-0

7 January 2021

Sleep disturbance is associated with cardiovascular and metabolic disorders

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970039-0

7 January 2021

Subjective sleep complaints are associated with insulin resistance in individuals without diabetes: the PPP-Botnia Study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970039-0

7 January 2021

Sleep-disordered breathing, glucose intolerance, and insulin resistance

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970039-0

7 January 2021

Snoring as a risk factor for type II diabetes mellitus: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970039-0

7 January 2021

Sleep-disordered breathing and glucose metabolism in hypertensive men: a population-based study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970039-0

7 January 2021

Obstructive sleep apnea and type 2 diabetes: is there a link?

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970039-0

7 January 2021

Do sleep disorders and associated treatments impact glucose metabolism?

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970039-0

7 January 2021

Sleep Apnea and Metabolic Dysfunction: Cause or Co-Relation?

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970039-0

7 January 2021

Prevalence of obstructive sleep apnoea in men with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970039-0

7 January 2021

Sleep-disordered breathing, glucose intolerance, and insulin resistance: the Sleep Heart Health Study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970039-0

7 January 2021

Association of sleep apnea and type II diabetes: a population-based study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970039-0

7 January 2021

Disorders of glucose metabolism in sleep apnea.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970039-0

7 January 2021

Effect of hypoxia on blood glucose, hormones, and insulin receptor functions in newborn calves

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970039-0

7 January 2021

The effect of hypoxia on plasma leptin and insulin in newborn and juvenile rats

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970039-0

7 January 2021

Effect of neonatal hypoxia on leptin, insulin, growth hormone and body composition in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970039-0

7 January 2021

Intermittent hypoxia increases insulin resistance in genetically obese mice

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970039-0

7 January 2021

Women at altitude: short-term exposure to hypoxia and/or alpha(1)-adrenergic blockade reduces insulin sensitivity

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970039-0

7 January 2021

The effect of altitude hypoxia on glucose homeostasis in men

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970039-0

7 January 2021

Effects of acute intermittent hypoxia on glucose metabolism in awake healthy volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970039-0

7 January 2021

Hypoxia causes glucose intolerance in humans.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970039-0

7 January 2021

Association of sleep time with diabetes mellitus and impaired glucose tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970039-0

7 January 2021

Short sleep duration is associated with insulin resistance independent of adiposity in Chinese adult twins

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970039-0

7 January 2021

Relation of sleep quality and sleep duration to type 2 diabetes: a population-based cross-sectional survey

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970039-0

7 January 2021

Impact of sleep debt on metabolic and endocrine function

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970039-0

7 January 2021

Effects of sleep fragmentation on glucose metabolism in normal subjects

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970039-0

7 January 2021

Slow-wave sleep and the risk of type 2 diabetes in humans

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970039-0

7 January 2021

Is high and fluctuating muscle nerve sympathetic activity in the sleep apnoea syndrome of pathogenetic importance for the development of hypertension?

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970039-0

7 January 2021

Influence of ventilation and hypocapnia on sympathetic nerve responses to hypoxia in normal humans

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970039-0

7 January 2021

Contrasting effects of hypoxia and hypercapnia on ventilation and sympathetic activity in humans

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970039-0

7 January 2021

Relationship of arousals from sleep to sympathetic nervous system activity and BP in obstructive sleep apnea

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970039-0

7 January 2021

Epinephrine exerts opposite effects on peripheral glucose disposal and glucose-stimulated insulin secretion. A stable label intravenous glucose tolerance test minimal model study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970039-0

7 January 2021

Central nervous system circuitry involved in the hyperinsulinism syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970039-0

7 January 2021

Adipokines in obesity

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970039-0

7 January 2021

Leptin in human physiology and pathophysiology.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970039-0

7 January 2021

Role of leptin in the pancreatic β-cell: effects and signaling pathways.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970039-0

7 January 2021

Adiponectin: regulation of its production and its role in human diseases

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970039-0

7 January 2021

Adipose tissue dysfunction in obesity, diabetes, and vascular diseases

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970039-0

7 January 2021

Reduced levels of adiponectin in sleep apnea syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970039-0

7 January 2021

Plasma levels of adiponectin, a novel adipocyte-derived hormone, in sleep apnea.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970039-0

7 January 2021

Serum adiponectin levels in adult male patients with obstructive sleep apnea hypopnea syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970039-0

7 January 2021

Adipose-derived resistin and gut-derived resistin-like molecule-beta selectively impair insulin action on glucose production

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970039-0

7 January 2021

A family of tissue-specific resistin-like molecules

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970039-0

7 January 2021

Resistin is not associated with insulin sensitivity or the metabolic syndrome in humans

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970039-0

7 January 2021

Cardiovascular consequences of sleep apnea.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970039-0

7 January 2021

Effect of continuous positive airway pressure on hemoglobin A(1c) in patients with obstructive sleep apnea: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970039-0

7 January 2021

Effects of continuous positive airway pressure on glycemic control and insulin resistance in patients with obstructive sleep apnea: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970039-0

7 January 2021

CPAP for the metabolic syndrome in patients with obstructive sleep apnea.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970039-0

7 January 2021

Prevalence of sleep apnea in a population of adults with type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970039-0

7 January 2021

Obstructive sleep apnea among obese patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970039-0

7 January 2021

Prevalence of diagnosed sleep apnea among patients with type 2 diabetes in primary care.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970039-0

7 January 2021

Diabetes and sleep disturbances: findings from the Sleep Heart Health Study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970039-0

7 January 2021

Diabetes is an independent risk factor for severe nocturnal hypoxemia in obese patients. A case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970039-0

7 January 2021

Autonomic neuropathy increases the risk of obstructive sleep apnea in obese diabetics.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970039-0

7 January 2021

Nocturnal oxygen desaturation in diabetic patients with severe autonomic neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970039-0

7 January 2021

Sleep apnoea in diabetic patients with autonomic neuropathy.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970039-0

7 January 2021

Altered control of ventilation in streptozotocin-induced diabetic rats

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970039-0

7 January 2021

Influence of autonomic neuropathy of different severities on the hypercapnic drive to breathing in diabetic patients.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970039-0

7 January 2021

Characteristics of sleep-disordered breathing in Japanese patients with type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970039-0

7 January 2021

The predictors of central and obstructive sleep apnoea in haemodialysis patients.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970039-0

7 January 2021

Sleep-disordered breathing in nonobese diabetic subjects with autonomic neuropathy.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970039-0

7 January 2021

Obstructive sleep apnoea and diabetes mellitus: the role of cardiovascular autonomic neuropathy.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970039-0

7 January 2021

Prevalence of sleep apnoea in diabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970039-0

7 January 2021

Obstructive sleep apnea increases hemoglobin A1c levels regardless of glucose tolerance status.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970039-0

7 January 2021

Impact of untreated obstructive sleep apnea on glucose control in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970039-0

7 January 2021

Clinical manifestations and current treatment options for diabetic neuropathies

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970039-0

7 January 2021

Longitudinal study of moderate weight change and sleep-disordered breathing

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970039-0

7 January 2021

Progression and regression of sleep-disordered breathing with changes in weight: the Sleep Heart Health Study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970039-0

7 January 2021

The impact of diet and lifestyle management strategies for obstructive sleep apnoea in adults: a systematic review and meta-analysis of randomised controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970039-0

7 January 2021

Physical exercise related improvement in obstructive sleep apnea. Look for the rostral fluid shift

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970039-0

7 January 2021

Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970039-0

7 January 2021

Physical activity of moderate intensity and risk of type 2 diabetes: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970039-0

7 January 2021

A controlled trial of CPAP therapy on metabolic control in individuals with impaired glucose tolerance and sleep apnea

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970039-0

7 January 2021

Role of obstructive sleep apnea in cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970039-0

7 January 2021

A randomized study on the effect of weight loss on obstructive sleep apnea among obese patients with type 2 diabetes: the Sleep AHEAD study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970039-0

7 January 2021

Effect of a very low energy diet on moderate and severe obstructive sleep apnoea in obese men: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970039-0

7 January 2021

Lifestyle intervention with weight reduction: first-line treatment in mild obstructive sleep apnea

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970039-0

7 January 2021

Sustained improvement in mild obstructive sleep apnea after a diet- and physical activity-based lifestyle intervention: postinterventional follow-up.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970039-0

7 January 2021

Value of weight reduction in patients with cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970039-0

7 January 2021

10.1016/S2213-2600(13)70039-0

Identifiers

DOI

1 reference

30 August 2017

1 reference